# A Single Dose Study of Debio 1450 in Healthy Subjects

> **NCT02162199** · PHASE1 · COMPLETED · sponsor: **Debiopharm International SA** · enrollment: 48 (actual)

## Conditions studied

- Bacterial Infections

## Interventions

- **DRUG:** Debio 1450
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02162199
- **Lead sponsor:** Debiopharm International SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2014-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02162199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02162199, "A Single Dose Study of Debio 1450 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02162199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*